Cooperation with the Medical Research Agency (MRA)

On 5 April this year, HM prof. dr. hab. Paweł Czarnecki, MBA, DBA, LL.M, MPH, Dr. h.c. – Provost of Uczelnia Biznesu i Nauk Stosowanych „Varsovia”, signed a cooperation agreement regarding the development of scientific activities with prof. dr. hab. n. med. Radosław Sierpiński – President of the Medical Research Agency.

– The conclusion of the agreement with Uczelnia Biznesu i Nauk Stosowanych „Varsovia” is a significant step in building management competences in the clinical trials sector in Poland. Organising permanent postgraduate education in clinical trials, such as in the field of MBA studies, is an important element of building a competent staff and an unquestionable direction that we must take in order to create a responsible and professional sector of biotechnology and clinical trials in Poland – emphasised the President of MRA, prof. Radosław Sierpiński.

– Cooperation with the Medical Research Agency (MRA) is a prestigious and practical opportunity to expand the competences of our students in MBA Clinical Research. These skills are necessary for the proper management and monitoring of clinical trials. Such an important partnership is a guarantee of the highest quality of education for future managers in the field of clinical trials that we are able to provide – said prof. dr. hab. Paweł Czarnecki, Provost of Uczelnia Biznesu i Nauk Stosowanych „Varsovia”.

There are various postgraduate management study programmes in the areas of clinical research, pharmacy and health protection offered at Uczelnia Biznesu i Nauk Stosowanych „Varsovia”:

MBA – Clinical Research

MBA – Healthcare Management

MBA – Pharmaceutical Management

MPH – Public Health

DBA – Clinical Research

DBA – Healthcare Management

DPH – Doctor of Public Health

Full offer and descriptions of our study programmes is available at:

Studia MBA